SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-026684
Filing Date
2024-03-27
Accepted
2024-03-27 17:30:21
Documents
4
Period of Report
2024-03-27

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0202747-6k_akanda.htm 6-K 18637
2 FORM OF UNDERWRITING AGREEMENT ea020274701ex1-1_akanda.htm EX-1.1 209605
3 FORM OF PRE-FUNDED WARRANT ea020274701ex4-1_akanda.htm EX-4.1 119366
4 AKANDA CORP. ANNOUNCES CLOSING OF UNDERWRITTEN PUBLIC OFFERING ea020274701ex99-1_akanda.htm EX-99.1 13692
  Complete submission text file 0001213900-24-026684.txt   362374
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41324 | Film No.: 24792201
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)